Vanda Pharma Inc Live Stock Price Today, Share Analysis and Chart

Name: Vanda Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Vanda Pharmaceuticals Inc
Rating: 1.594208375
Author: Trendlyne DVM scores

Momentum Trap

about

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ f...

7.54 -0.24 (-3.08%)

97.90% Gain from 52W Low

766.7K

XNAS Volume

XNAS 30 Jan, 2026 4:00 PM (EST)

Low Financial Strength

16.7 / 100

Expensive Valuation

26.8 / 100

Technically Moderately Bullish

67.4 / 100

Momentum Trap These stocks have weak financials and expensive valuation. Buying interest may quickly dissipate. Investors should exercise caution View Similar Embed DVM

1Yr Price target upside is 81%

4 analysts

Vanda Pharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Vanda Pharma Inc Live Stock Price Today, Share Analysis and Chart

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ f...

97.90% Gain from 52W Low

SWOT Analysis

Vanda Pharma Inc Live Price Chart